These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9602696)

  • 1. A case of systemic pseudo-pseudoxanthoma elasticum with diverse symptomatology caused by long-term penicillamine use.
    Coatesworth AP; Darnton SJ; Green RM; Cayton RM; Antonakopoulos GN
    J Clin Pathol; 1998 Feb; 51(2):169-71. PubMed ID: 9602696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist?
    Ibáñez-Samaniego L; Ochoa-Palominos A; Catalina-Rodríguez MV; Salcedo-Plaza M; Clemente-Ricote G
    Rev Esp Enferm Dig; 2015 Mar; 107(3):190-1. PubMed ID: 25733050
    [No Abstract]   [Full Text] [Related]  

  • 3. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine.
    Bécuwe C; Dalle S; Ronger-Savlé S; Skowron F; Balme B; Kanitakis J; Thomas L
    Dermatology; 2005; 210(1):60-3. PubMed ID: 15604549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillamine induced pseudoxanthoma elasticum with elastosis perforans serpiginosa.
    Rath N; Bhardwaj A; Kar HK; Sharma PK; Bharadwaj M; Bharija SC
    Indian J Dermatol Venereol Leprol; 2005; 71(3):182-5. PubMed ID: 16394408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin.
    Ratnavel RC; Norris PG
    Dermatology; 1994; 189(1):81-3. PubMed ID: 8003796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoxanthoma-elasticum-like skin changes induced by penicillamine.
    Bolognia JL; Braverman I
    Dermatology; 1992; 184(1):12-8. PubMed ID: 1558988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Pseudo-pseudoxanthoma Elasticum Resulting From D-Penicillamine Treatment for Wilson Disease.
    Yu Z; Sheu Song J; Schmidt B; Corey K; Hawryluk EB
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):731-733. PubMed ID: 32796424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoxanthoma elasticum-like skin changes induced by penicillamine.
    Bentley-Phillips B
    J R Soc Med; 1985 Sep; 78(9):787. PubMed ID: 4045909
    [No Abstract]   [Full Text] [Related]  

  • 9. Penicillamine-induced pseudoxanthoma elasticum-like skin changes requiring rhytidectomy.
    Narron GH; Zec N; Neves RI; Manders EK; Sexton FM
    Ann Plast Surg; 1992 Oct; 29(4):367-70. PubMed ID: 1466536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-penicillamine-induced pseudo-pseudoxanthoma elasticum and extensive elastosis perforans serpiginosa with excellent response to acitretin.
    Chisti MA; Binamer Y; Alfadley A; Almutawa A
    Ann Saudi Med; 2019; 39(1):56-60. PubMed ID: 30712052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elastic fibre damage induced by low-dose D-penicillamine.
    Dalziel KL; Burge SM; Frith PA; Ryan TJ; Mowat A
    Br J Dermatol; 1990 Sep; 123(3):305-12. PubMed ID: 2206970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoxanthoma elasticum-like skin changes induced by penicillamine.
    Meyrick Thomas RH; Light N; Stephens AD; Avery NC; Kirby JD
    J R Soc Med; 1984 Sep; 77(9):794-8. PubMed ID: 6481758
    [No Abstract]   [Full Text] [Related]  

  • 15. Collagen and elastin changes in D-penicillamine-induced pseudoxanthoma elasticum-like skin.
    Light N; Meyrick Thomas RH; Stephens A; Kirby JD; Fryer PR; Avery NC
    Br J Dermatol; 1986 Mar; 114(3):381-8. PubMed ID: 3954958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillamine: the treatment of first choice for patients with Wilson's disease.
    Walshe JM
    Mov Disord; 1999 Jul; 14(4):545-50. PubMed ID: 10435489
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease.
    Neri I; Gurioli C; Raggi MA; Saracino MA; Morganti E; Bugamelli F; de Ponti F; Vaccari S; Patrizi A; Balestri R
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):383-386. PubMed ID: 24404914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease.
    Hill VA; Seymour CA; Mortimer PS
    Br J Dermatol; 2000 Mar; 142(3):560-1. PubMed ID: 10777259
    [No Abstract]   [Full Text] [Related]  

  • 20. Elastosis perforans serpiginosa and pseudoxanthoma elasticum-like skin change due to D-penicillamine.
    Meyrick Thomas RH; Kirby JD
    Clin Exp Dermatol; 1985 Jul; 10(4):386-91. PubMed ID: 4042411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.